路人丙
【新闻事件】:今天英国生物技术公司Bicycle Therapeutics宣布将在美国IPO(BCYC),目标募资8250万美元。BCYC是一家以多肽为技术平台的公司,利用双环控制多肽构象、以增加选择性和稳定性。BCYC成立于2009年,其核心资产是一...查看全文
$Bicycle Therapeutics(BCYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-046415 Size: 27 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-045304 Size: 20 KB 网页链接
$Bicycle Therapeutics(BCYC)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-048601 Act: 34 Size: 182 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001104659-24-048576 Act: 34 Size: 420 KB 网页链接
$Bicycle Therapeutics(BCYC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-048578 Act: 34 Size: 164 KB 网页链接
$Bicycle Therapeutics(BCYC)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005119 Act: 34 Size: 3 MB 网页链接
$Bicycle Therapeutics(BCYC)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-047270 Act: 34 Size: 8 MB 网页链接
$Bicycle Therapeutics(BCYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010760 Size: 5 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000100 Act: 33 Size: 4 KB 网页链接
$Bicycle Therapeutics(BCYC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010415 Size: 5 KB 网页链接